Atrial Fibrillation Clinical Trials in Tucson, Arizona

4 studies are recruiting for atrial fibrillation in Tucson, Arizona right now. Each one is listed on ClinicalTrials.gov, the public registry the research teams themselves file with. TrialBoost is not a doctor, a research site, or a study sponsor: the research team decides who takes part.

Search these by distance from you

Studies now recruiting

  1. A Study Assessing Long-Term Safety and Effectiveness in Treatment Management of Atrial Fibrillation With VARIPULSE Catheter System

    The purpose of this study is to evaluate the long-term safety and effectiveness of the FDA approved VARIPULSE catheter system for pulmonary vein isolation (PVI) in the treatment of participants with symptomatic paroxysmal atrial fibrillation (PAF).

    Stage
    Not phased
    Ages
    22 and older
    Site
    Tucson Medical Center Pima Heart and Vascular, Tucson, Arizona
    Locations
    22 in total
    Run by
    Biosense Webster, Inc.

    See if you can join NCT07227532 on ClinicalTrials.gov

  2. A Study of VARIPULSE Catheter in Participants With Persistent Atrial Fibrillation Undergoing Pulmonary Vein and Superior Vena Cava Isolation

    The purpose of this study is to assess how safe VARIPULSE catheter system is for treatment of a heart rhythm disease called persistent atrial fibrillation (PsAF) in participants who are having a catheter ablation procedure (treat heart rhythm disease). This includes isolation of pulmonary vein and …

    Stage
    Not phased
    Ages
    18 to 80
    Site
    Pima Heart and Vascular, Tucson, Arizona
    Locations
    3 in total
    Run by
    Biosense Webster, Inc.

    See if you can join NCT07527299 on ClinicalTrials.gov

  3. Anticoagulation in ICH Survivors for Stroke Prevention and Recovery

    Primary Aim: To determine if apixaban is superior to aspirin for prevention of the composite outcome of any stroke (hemorrhagic or ischemic) or death from any cause in patients with recent ICH and atrial fibrillation (AF). Secondary Aim: To determine if apixaban, compared with aspirin, results in b…

    Stage
    Phase 3
    Ages
    18 and older
    Site
    Banner University Medical Center, Tucson, Arizona
    Locations
    187 in total
    Run by
    Yale University

    See if you can join NCT03907046 on ClinicalTrials.gov

  4. CardioFocus HeartLight Post-Approval Study

    This is a post-approval study to evaluate the clinical outcomes in a cohort of participants treated during commercial use of the HeartLight System to confirm results of the previously conducted pivotal clinical study.

    Stage
    Not phased
    Ages
    18 and older
    Site
    University of Arizona Sarver HeartCenter, Tucson, Arizona
    Locations
    4 in total
    Run by
    CardioFocus

    See if you can join NCT03168659 on ClinicalTrials.gov

How to read this page. Every study here comes from ClinicalTrials.gov, the public registry that research teams are required to file with. We have summarised each one in plain language and shown where it is running. We have not changed what any study says it is doing.

What TrialBoost is. We help people find research that might suit them, and, if they ask us to, we pass their details to the research team running it. We are not a doctor, a research site, or a study sponsor, and we do not decide who takes part in anything. Joining costs nothing and you can change your mind at any point.

Paid placement. Some studies pay us when someone asks to be connected to them. Those are labelled Sponsored wherever they appear, and they only appear when they match what you were actually looking for.